Advertisement

Journal of General Internal Medicine

, Volume 13, Issue 6, pp 357–365 | Cite as

Chronic disease as a barrier to breast and cervical cancer screening

  • Catarina I. Kiefe
  • Ellen Funkhouser
  • Mona N. Fouad
  • Daniel S. May
Original Articles

Abstract

OBJECTIVE: To assess whether chronic disease is a barrier to screening for breast and cervical cancer.

DESIGN: Structured medical record review of a retrospectively defined cohort.

SETTING: Two primary care clinics of one academic medical center.

PATIENTS: All eligible women at least 43 years of age seen during a 6-month period in each of the two study clinics (n=1,764).

MEASUREMENTS AND MAIN RESULTS: Study outcomes were whether women had been screened: for mammogram, every 2 years for ages 50–74; for clinical breast examinations (CBEs), every year for all ages; and for Pap smears, every 3 years for ages under 65. An index of comorbidity, adapted from Charlson (0 for no disease, maximum index of 8 among our patients), and specific chronic diseases were the main independent variables. Demographics, clinic use, insurance, and clinical data were covariates. In the appropriate age groups for each test, 58% of women had a mammogram, 43% had a CBE, and 66% had a Pap smear. As comorbidity increased, screening rates decreased (p<.05 for linear trend). After adjustment, each unit increase in the comorbidity index corresponded to a 17% decrease in the likelihood of mammography (p=.005), 13% decrease in CBE (p=.006), and 20% decrease in Pap smears (p=.002). The rate of mammography in women with stable angina was only two fifths of that in women without.

CONCLUSIONS: Among women who sought outpatient care, screening rates decreased as comorbidity increased. Whether clinicians and patients are making appropriate decisions about screening is not known.

Key words

mass screening breast cancer cervical cancer comorbidity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    La Vecchia C, Decarli A, Gentile A, et al. Pap smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet. 1984;2:779–82.PubMedCrossRefGoogle Scholar
  2. 2.
    Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA. 1995;273(2):149–54.PubMedCrossRefGoogle Scholar
  3. 3.
    US Preventive Services Task Force, Guide to Clinical Prevention Services. 2nd ed. Baltimore, MD: Williams & Wilkins; 1996.Google Scholar
  4. 4.
    Anderson LM, May DS. Has the use of the cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health. 1995;85(6):840–2.PubMedGoogle Scholar
  5. 5.
    Trends in cancer screening—United States, 1987 and 1992. MMWR. 1996;45(3):57–61.Google Scholar
  6. 6.
    Bastani R, Marcus AC, Hollatz-Brown A. Screening mammography rates and barriers to use: a Los Angeles County survey. Prev Med. 1991;20:350–63.PubMedCrossRefGoogle Scholar
  7. 7.
    Love RR, Brown RL, Davis JE, Baumann LJ, Fontana SA, Sanner LA. Frequency and determinants of screening for breast cancer in primary care group practice. Arch Intern Med. 1993;153:2113–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Dolan NC, Reifler DR, McDermott MM, McGaghie WC. Adherence to screening mammography recommendations in a university general medicine clinic. J Gen Intern Med. 1995;10:299–306.PubMedCrossRefGoogle Scholar
  9. 9.
    Grady KE, Lemkau JP, McVay JM, et al. Clinical decision-making and mammography referral. Prev Med. 1996;25:327–38.PubMedCrossRefGoogle Scholar
  10. 10.
    Costanza ME, Stoddard AM, Zapka JG, Gaw VP, Barth R. Physician compliance with mammography guidelines: barriers and enhances. J Am Board Fam Pract. 1992;5(2):143–52.PubMedGoogle Scholar
  11. 11.
    Kiefe CI, McKay SV, Halevy A, Brody AB. Is cost a barrier to screening mammography for low-income women receiving Medicare benefits? A randomized trial. Arch Intern Med. 1994;154:1217–24.PubMedCrossRefGoogle Scholar
  12. 12.
    Herman CJ, Speroff T, Cebul RD. Improving compliance with breast cancer screening in older women. Results of a randomized controlled trial. Arch Intern Med. 1995;155:717–22.PubMedCrossRefGoogle Scholar
  13. 13.
    Zapka JG, Harris DR, Hosmer D, Costanza ME, Mas E, Barth R. Effect of a community health center intervention on breast cancer screening among Hispanic American women. Health Serv Res. 1993;28(2):223–35.PubMedGoogle Scholar
  14. 14.
    Fletcher SW, Harris RP, Gonzalez JJ, et al. Increasing mammography utilization: a controlled study. J Natl Cancer Inst. 1993;85(2):112–20.PubMedCrossRefGoogle Scholar
  15. 15.
    Luke K. Cervical cancer screening: meeting the needs of minority ethnic women. Br J Cancer. 1996;29(suppl):S47–50.Google Scholar
  16. 16.
    McGregor SE, Leinweber CE. Involving family physicians in education programs for cervical cancer screening. Ann NY Acad Sci. 1995;768:289–91.PubMedCrossRefGoogle Scholar
  17. 17.
    Orbell S, Crombie I, Robertson A, Johnston G, Kenicer M. Assessing the effectiveness of a screening campaign: who is missed by 80% cervical screening coverage? J R Soc Med. 1995;88(7):389–94.PubMedGoogle Scholar
  18. 18.
    Lubitz RM, Litzelman DK, Dittus RS, Tierney WM. Is obesity a barrier to physician screening for cervical cancer? Am J Med. 1995;98(5):491–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Austoker J. Cancer prevention in primary care. Screening for cervical cancer. BMJ. 1994;309(6949):241–8. Review. Published erratum appears in BMJ. 1994;309(6952):452.PubMedGoogle Scholar
  20. 20.
    Smith RA, Haynes S. Barriers to screening for breast cancer. Cancer. 1992;69(7 suppl):1968–78. Review.PubMedCrossRefGoogle Scholar
  21. 21.
    Satariano WA. Comorbidity and functional status in older women with breast cancer: implications for screening, treatment, and prognosis. J Gerontol. 1992;47:24–31.PubMedGoogle Scholar
  22. 22.
    Hoffman C, Rice DP, Chronic Care in America: A 21st Century Challenge. Princeton, NJ: Robert Wood Johnson Foundation; 1996.Google Scholar
  23. 23.
    Bostick RM, Sprafka JM, Virnig BA, Potter JD. Predictors of cancer prevention attitudes and participation in cancer screening examinations. Prev Med. 1994;23:816–26.PubMedCrossRefGoogle Scholar
  24. 24.
    Grady KE, Lemkau JP, McVay JM, Reisine ST. The importance of physician encouragement in breast cancer screening of older women. Prev Med. 1992;21:766–80.PubMedCrossRefGoogle Scholar
  25. 25.
    Burack RC, Liang J. The acceptance and completion of mammography by older black women. Am J Public Health. 1989;79(6):721–6.PubMedGoogle Scholar
  26. 26.
    Shoen RE, Marcus M, Braham RL. Factors associated with the use of screening mammography in a primary care setting. J Community Health. 1994;19(4):239–52.CrossRefGoogle Scholar
  27. 27.
    Rosner BA. Fundamentals of Biostatistics. 4th ed. Belmont, Calif: Wadsworth; 1995.Google Scholar
  28. 28.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373–83.PubMedCrossRefGoogle Scholar
  29. 29.
    Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.PubMedCrossRefGoogle Scholar
  30. 30.
    US Preventive Services Task Force. Guide to Clinical Preventive Services. Baltimore, Md: Williams & Wilkins; 1989.Google Scholar
  31. 31.
    Mandelblatt J, Traxler M, Lakin P, et al. Breast and cervical cancer screening of poor, elderly, black women: clinical results and implications. Am J Prev Med. 1993;9(3):133–8.PubMedGoogle Scholar
  32. 32.
    US Department of Health and Human Services. Healthy People 2000. Washington, DC: Public Health Service; 1990.Google Scholar
  33. 33.
    US Department of Health and Human Services. Healthy People 2000. Midcourse Review and 1995;Revisions. Washington, DC: Public Health Service; 1995.Google Scholar
  34. 34.
    Dolan NC, Reifler DR, McDermott MM, McGaghie WC. Adherence to screening mammography recommendations in a university general medicine clinic. J Gen Intern Med. 1995;10:299–306.PubMedCrossRefGoogle Scholar
  35. 35.
    Ackermann SP, Cheal N. Factors affecting physician adherence to breast cancer screening guidelines. J Cancer Educ. 1994;9(2):96–100.PubMedGoogle Scholar
  36. 36.
    Chao A, Paganini-Hill A, Ross RK, Henderson BE. Use of preventive care by the elderly. Prev Med. 1987;16:710–22.PubMedCrossRefGoogle Scholar
  37. 37.
    Mor V, Pacala JT, Rakowski W. Mammography for older women: who uses, who benefits? J Gerontol. 1992;47:43–9. Review.PubMedGoogle Scholar
  38. 38.
    Costanza ME. Breast cancer screening in older women: overview. J Gerontol. 1992;47:1–3.PubMedGoogle Scholar
  39. 39.
    Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chron Dis. 1970;23:445–68.CrossRefGoogle Scholar
  40. 40.
    Crawford J, Cohen HJ. Aging and neoplasia. Ann Rev Gerontol Geriatr. 1985;4:3–32.Google Scholar
  41. 41.
    Jaén CR, Stange KC, Nutting PA. Competing demands of primary care: a model for the delivery of clinical preventive services. J Fam Pract. 1994;38:166–71.PubMedGoogle Scholar
  42. 42.
    Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994;120:104–10.PubMedGoogle Scholar
  43. 43.
    Boer R, de Koning HJ, van Oortmarssen GJ, van der Maas PJ. In search of the best upper age limit for breast cancer screening. Eur J Cancer. 1995;31A(12):2040–3.PubMedCrossRefGoogle Scholar
  44. 44.
    National Center for Health Statistics. Health, United States, 1996–97 and Injury Chartbook. Hyattsville, Md: Public Health Service; 1997:77.Google Scholar
  45. 45.
    Mandelblatt JS, Wheat ME, Monane M, Moshief RD, Hollenberg JP, Tang J. Breast cancer screening for elderly women with and without comorbid conditions. Ann Intern Med. 1992;116:722–30.PubMedGoogle Scholar
  46. 46.
    Fetters MD, Fischer G, Reed BD. Effectiveness of vaginal Papanicolaou smear screening after total hysterectomy for benign disease. JAMA. 1996;275(12):940–7. Review.PubMedCrossRefGoogle Scholar
  47. 47.
    Pearce KF, Haefner HK, Sarwar SF, Nolan TE. Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic diseases. N Engl J Med. 1996;335(21):1559–62.PubMedCrossRefGoogle Scholar
  48. 48.
    Etzi S, Lane DS, Grimson R. The use of mammography vans by low-income women: the accuracy of self-reports. Am J Public Health. 1994;84(1):107–9.PubMedGoogle Scholar
  49. 49.
    Montano DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health. 1995;85(6):795–800.PubMedCrossRefGoogle Scholar
  50. 50.
    West DW, Satariano WA, Ragland DR, Hiatt RA. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol. 1996;6(5):413–9.PubMedCrossRefGoogle Scholar
  51. 51.
    Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existing disease in the occurrence of post-operative complications and one-year recovery in patients undergoing total hip replacement. Med Care. 1993;31(2):141–54.PubMedCrossRefGoogle Scholar
  52. 52.
    Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chron Dis. 1974;27:387–404.PubMedCrossRefGoogle Scholar
  53. 53.
    Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16:622–6.PubMedGoogle Scholar
  54. 54.
    Krousel-Wood MA, Abdoh A, Re R. Comparing comorbid-indices assessing outcome variation: the case of prostatectomy. J Gen Intern Med. 1996;11:32–8.PubMedCrossRefGoogle Scholar
  55. 55.
    Rochon PA, Katz JN, Morrow LA, et al. Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability: a prospective comparison of three comorbidity indices. Med Care. 1996;34(11):1093–1101.PubMedCrossRefGoogle Scholar
  56. 56.
    Greenfield S, Sullivan L, Dukes KA, Silliman R, D’Agostino R, Kaplan SH. Development and testing of a new measure of case mix for use in office practice. Med Care. 1995;33(4):AS47–55.PubMedGoogle Scholar
  57. 57.
    Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. Cancer. 1996;46(1):5–27.Google Scholar

Copyright information

© Society of General Internal Medicine 1998

Authors and Affiliations

  • Catarina I. Kiefe
    • 3
    • 1
  • Ellen Funkhouser
    • 3
  • Mona N. Fouad
    • 3
  • Daniel S. May
    • 2
  1. 1.Veterans Affairs Medical CenterBirmingham
  2. 2.Centers for Disease Control and PreventionAtlanta
  3. 3.University of Alabama at BirminghamBirmingham

Personalised recommendations